Dw. Pyatt et al., HYDROQUINONE, A REACTIVE METABOLITE OF BENZENE, INHIBITS NF-KAPPA-B IN PRIMARY HUMAN CD4(-LYMPHOCYTES() T), Toxicology and applied pharmacology, 149(2), 1998, pp. 178-184
Hydroquinone (HQ), a reactive metabolite of benzene, is present in cig
arette smoke and is known to inhibit mitogen-stimulated activation of
both T and B lymphocytes. Despite extensive study, the underlying mech
anism for HQ's immunotoxicity is not clear. NF-kappa B is a transcript
ion factor known to regulate the expression of a number of genes criti
cal for normal T cell activation. We therefore hypothesized that NF-ka
ppa B might be involved in HQ-induced immunosuppression. In this study
, we demonstrate that 1 mu M HQ inhibits tumor necrosis factor or indu
ced activation of NF-kappa B in primary human CD4(+) T cells. This inh
ibition is not accompanied by a loss in viability, and HQ-treated T ce
lls maintain other active signaling pathways throughout the exposure d
uration. Additionally, the inhibition of NF-kappa B is reversible as H
Q-treated T cells regain normal functioning after 72 h in culture. HQ
does not appear to alter NF-kappa B directly as preincubation of nucle
ar extracts with HQ does not diminish activity of this protein. We fur
ther demonstrate that 1 mu M HQ inhibits intracellular IL-2 production
in T cells stimulated with phorbol ester but does not alter surface e
xpression of CD25 (the alpha-subunit of the IL-2 receptor). These data
suggest that NF-kappa B may be an important molecular mediator of HQ'
s land benzene's) immunotoxicity. (C) 1998 Academic Press.